Hepatitis C Virus (HCV) Reinfection and Injection Risk Behavior Following Elbasvir/Grazoprevir (EBR/GZR) Treatment in Patients on Opioid Agonist Therapy (OAT): Costar Three-Year Follow-Up Study
Year: 2017
Type: article
Source: Gastroenterology
Authors: Barbara Haber, Edward Gane, Gregory J. Dore, Jason Grebely, Frederick Altice, Alain H. Litwin, Olav Dalgard, Oren Shibolet, Anne Luetkemeyer, Ronald Nahass, Cheng-Yuan Peng, Brian Conway, David M. Iser, Hsueh-Cheng Huang, Isaias N. Gendrano, Michelle Kelly, Peggy Hwang, Michael Robertson, Janice Wahl, Eliav Barr, Heather L. Platt
Language: English
Topic: Hepatitis C virus research
Subfield: Hepatology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2606829580